A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system
The current comprehensive pharmacovigilance study identified more drugs associated with NMS and provides references to clinicians for clinical practice. Also, further research is needed to investigate the causal relationship between these drugs and NMS.
Authors
- Yu Zhang (ORCID: https://orcid.org/0000-0003-1025-906X)
- Song Li (ORCID: https://orcid.org/0000-0002-4760-8828)
- Siying Luo (ORCID: https://orcid.org/0009-0002-1929-956X)
- Min‐Jian Wang
- Wei Deng (ORCID: https://orcid.org/0000-0001-5937-9877)
Institutions
- Chongqing City Mental Health Center (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.3389/fphar.2024.1438661
- Citations
- 5
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.93